Archive · 25 Jul 2025
Laurus Labs Invests in KRKA Pharma for New Manufacturing Unit
Laurus Labs, a company, is putting about Rs 45 crore into KRKA Pharma, a company they jointly own.
This money will help build a new factory to make medicines.
Another company, KRKA d.d., will also invest a similar amount, and the ownership of the two companies won't change.
The new factory will sell medicines in India and other countries.
Laurus Labs also made a lot more money this past quarter than they did last year.
Laurus Labs to invest approximately Rs 45 crore in its joint venture KRKA Pharma.
The investment is intended for a new manufacturing facility for finished pharmaceutical products.
KRKA d.d. will also invest about Rs 45.75 crore, maintaining the 49:51 shareholding ratio.
The new facility will target the Indian and international markets.
Laurus Labs' Q1 profit surged to Rs 163 crore, up 1,154%.
- Who
- Laurus Labs and KRKA d.d. are involved in the investment.
- What
- Laurus Labs is investing in its joint venture, KRKA Pharma, for a new manufacturing unit.
- When
- The investment is expected to be completed by December 31, 2025. The news was reported on July 25.
- Where
- The new facility will cater to both Indian and international markets.
- Why
- The investment is for a new manufacturing facility to produce finished pharmaceutical products.
- Investment Amount (Laurus Labs)
- Approximately Rs 45 crore ( €5 million)
- Investment Amount (KRKA d.d.)
- Rs 45.75 crore
- Shareholding Ratio
- Laurus Labs 49%, KRKA d.d. 51%
- Facility Purpose
- Manufacturing finished pharmaceutical products
- Market Focus
- Indian and international markets
- Laurus Labs Q1 Profit
- Rs 163 crore (up 1,154%)